Participants were randomly assigned ( 2:1 ) to receive oral sitagliptin ( 100 mg for participants 18 years , 50 mg for those < 18 years ) and lansoprazole ( 60 mg for participants 18 years , 30 mg for those < 18 years ) or matched placebo for 12 months .